📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank. (2021)

First Author: Pisanu C

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.biopha.2021.112234

PubMed Identifier: 34649359

Publication URI: http://europepmc.org/abstract/MED/34649359

Type: Journal Article/Review

Volume: 143

Parent Publication: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

ISSN: 0753-3322